References
- Liu T, Ding S, Dang J, Wang H, Chen J, Li G. First-line immune checkpoint inhibitors for advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK): a systematic review and network meta-analysis. Journal of thoracic disease, [online] 11(7); 2019. pp. 2899–2912. DOI: 10.21037/jtd.2019.07.45
- Valabrega G, Montemurro F, Aglietta M. Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer. Annals of Oncology, 2007; 18(6): 977–984. DOI: 10.1093/annonc/mdl475
- DailyMed. Retrieved July 19, 2021; n.d. from
https://dailymed.nlm.nih.gov/dailymed . - openFDA. Retrieved July 29, 2023; n.d. from
https://open.fda.gov/ - Targeted Cancer Therapies Fact Sheet. Retrieved July 22, 2021; n.d. from
https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet . - Behnel S, Faassen M, Bicking I. lxml: XML and HTML with Python. Lxml; 2005.
- Neumann M, King D, Beltagy I, Ammar W. ScispaCy: Fast and Robust Models for Biomedical Natural Language Processing. Proceedings of the 18th BioNLP Workshop and Shared Task; 2019. DOI: 10.18653/v1/W19-5034
- Khandelwal A, Sawant S. NegBERT: A Transfer Learning Approach for Negation Detection and Scope Resolution. The 12th Language Resources and Evaluation Conference (LREC 2020); 2020.
https://aclanthology.org/2020.lrec-1.704.pdf . - Mahmood AS, Rao S, McGarvey P, Wu C, Madhavan S, Vijay-Shanker K. EGARD: Extracting associations between genomic anomalies and drug responses from text; 2017. DOI: 10.1101/148833